Robotin INC, an innovative technology company focused on the research, design, production, and marketing of AI and robotics, today announced the global launch of theRobotin R2 on Kickstarter, commencing September 23. As the world's first 2-in-1 modular carpet cleaning robot, the R2 breaks traditional cost and efficiency barriers, delivering households an unprecedented all-in-one solution. This […]
ZDoors has just unveiled a brand-new collection of beautiful, customisable fire doors and wall panels, reinforcing its position as one of the top door suppliers in Manchester and across the UK. The collection has beautiful finishes to choose from, including classic oak, elegant walnut, and sleek matt black. The collection is designed for anyone looking
Respected Industry Award Highlights Excellence in Wealth Management Freestone Capital Management (“Freestone”), a Seattle-based Registered Investment Advisor, is proud to announce that Managing Partner and Client Advisor Erik Morgan has been recognized by Barron's as one of the Top 100 Independent Advisors in the nation, earning the #6 ranking overall. This is the fourth year
Established in 1867 by William G. Bell in Boston, Bell's Seasoning is a staple across New England during the holidays. Its all‑natural, salt‑free spice blend has remained unchanged for over 150 years, with generations of home cooks trusting it for holiday feasts. Over the years, stuffing, gravy, brine, and fried onions have been added to
Pomerantz LLP is investigating claims on behalf of investors of Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Valneva and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for
Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. (“Axogen” or the “Company”) (NASDAQ: AXGN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Axogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for
Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited (“EHang” or the “Company”) (NASDAQ: EH).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether EHang and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of Skillz Inc. (“Skillz” or the “Company”) (NYSE: SKLZ). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Skillz and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for
Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherAgiosand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click
Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Summit and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here